Since our results indicate that KRAS suppression is associated with CpG methylation changes in pancreatic cancer cell lines, we hypothesized that the overexpression of oncogenic KRAS would also lead to DNA methylation changes. Here, KRAS is linked to familial pancreatic carcinoma.